In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds
Open Access
- 24 December 2024
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (2) , 293-307
Abstract
Tau pathology is a hallmark of several neurodegenerative diseases, including frontotemporal dementia and Alzheimer’s disease. However, the sequence of events and the form of tau that confers toxicity are still unclear, due in large part to the lack of physiological models of tauopathy initiation and progression in which to test hypotheses. We have developed a series of targeted mice expressing frontotemporal-dementia-causing mutations in the humanized MAPT gene to investigate the earliest stages of tauopathy. MAPT Int10+3G>A and MAPT S305N;Int10+3G>A lines show abundant hyperphosphorylated tau in the hippocampus and entorhinal cortex, but they do not develop seed-competent fibrillar structures. Accumulation of hyperphosphorylated tau was accompanied by neurite degeneration, loss of viable synapses and indicators of behavioral abnormalities. Our results demonstrate that neuronal toxicity can occur in the absence of fibrillar, higher-order structures and that tau hyperphosphorylation is probably involved in the earliest etiological events in tauopathies showing isoform ratio imbalance.Keywords
All Related Versions
Funding Information
- Japan Agency for Medical Research and Development (JP20dm0207001)
- MEXT | Japan Society for the Promotion of Science (21K15378)
- U.S. Department of Health & Human Services | National Institutes of Health (AG063521)
This publication has 84 references indexed in Scilit:
- Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in miceAlzheimer's & Dementia, 2024
- Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer DiseaseJAMA Neurology, 2023
- Roles of tau protein in health and diseaseActa Neuropathologica, 2017
- Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spinesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- Conditioned response suppression in the IntelliCage: assessment of mouse strain differences and effects of hippocampal and striatal lesions on acquisition and retention of memoryBehavioural Brain Research, 2010
- Another phenotype of frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17) with a missense mutation of S305N closely resembling Pick?s diseaseJournal of Neurology, 2003
- Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau TransgenesNeurobiology of Disease, 2000
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tauJournal of Neuroscience Research, 1997
- Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical traumaNeurotoxicology and Teratology, 1994